← Leaderboards
Alexei Bagrov
National Institute On Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Na(+)-K(+)-Exchanging Atpase”
- H. Ronald Zielke · University Of Maryland Baltimore$3,360,108
- Akhil B Vaidya · Drexel University$2,652,142
- Bradley M Palmer · University Of Vermont & St Agric College$1,890,480
- Allan W Wolkoff · Yeshiva University$1,849,572
- Christoph Hornik · Duke University$1,830,595
- Daniel B. Polley · Vanderbilt University$1,824,447
Research focus
Na(+)-K(+)-Exchanging AtpaseMarinobufageninBlood PressurePlasmaBlood VesselsRattusCollagenAntibodiesHypertensionPre-EclampsiaAgingSalt SensitiveFibrosisAtpase Inhibitory ProteinExhibitsResponseKidney Vascular StructureCardiac GlycosidesExcretory FunctionMonoclonal AntibodiesMuscle, Smooth, VascularNatriuresisNatriuretic FactorsSignal Transduction
Grant awards (24)
Marinobufagenin as a therapeutic target$626,177
ZIA · FY2016 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$640,227
ZIA · FY2015 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$634,510
ZIA · FY2015 · AG · contact PI
Marinobufagenin as a therapeutic target$543,049
ZIA · FY2015 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$568,846
ZIA · FY2014 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$566,150
ZIA · FY2014 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$566,150
ZIA · FY2014 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$445,413
ZIA · FY2013 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$438,030
ZIA · FY2013 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$418,343
ZIA · FY2013 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$614,813
ZIA · FY2012 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$581,580
ZIA · FY2012 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$365,564
ZIA · FY2012 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$377,262
ZIA · FY2011 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$261,181
ZIA · FY2011 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$217,651
ZIA · FY2011 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$282,921
ZIA · FY2010 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$195,869
ZIA · FY2010 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$163,224
ZIA · FY2010 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$440,482
ZIA · FY2009 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$350,127
ZIA · FY2009 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$327,538
ZIA · FY2009 · AG · contact PI
Development of a therapeutic anti-marinobufagenin antibody$466,691
Z01 · FY2008 · AG · contact PI
Aging and interaction of natriuretic factors on renal and vascular sodium pump$388,910
Z01 · FY2008 · AG · contact PI